Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle
Aims/hypothesis Muscle may experience hypoglycaemia during ischaemia or insulin infusion. During severe hypoglycaemia energy production is blocked, and an increase of AMP:ATP activates the energy sensor and putative insulin-sensitiser AMP-activated protein kinase (AMPK). AMPK promotes energy conserv...
Gespeichert in:
Veröffentlicht in: | Diabetologia 2012-03, Vol.55 (3), p.783-794 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 794 |
---|---|
container_issue | 3 |
container_start_page | 783 |
container_title | Diabetologia |
container_volume | 55 |
creator | Chopra, I. Li, H. F. Wang, H. Webster, K. A. |
description | Aims/hypothesis
Muscle may experience hypoglycaemia during ischaemia or insulin infusion. During severe hypoglycaemia energy production is blocked, and an increase of AMP:ATP activates the energy sensor and putative insulin-sensitiser AMP-activated protein kinase (AMPK). AMPK promotes energy conservation and survival by shutting down anabolism and activating catabolic pathways. We investigated the molecular mechanism of a unique glucose stress defence pathway involving AMPK-dependent, insulin-independent activation of the insulin signalling pathway.
Methods
Cardiac or skeletal myocytes were subjected to glucose and insulin-free incubation for increasing intervals up to 20 h. AMPK, and components of the insulin signalling pathway and their targets were quantified by western blot using phosphor-specific antibodies. Phosphomimetics were used to determine the function of IRS-1 Ser789 phosphorylation and in vitro [
32
P]ATP kinase assays were used to measure the phosphorylation of the purified insulin receptor by AMPK.
Results
Glucose deprivation increased Akt-Thr308 and Akt-Ser473 phosphorylation by almost tenfold. Phosphorylation of glycogen synthase kinase 3 beta increased in parallel, but phosphorylation of ribosomal 70S subunit-S6 protein kinase and mammalian target of rapamycin decreased. AMPK inhibitors blocked and aminoimidazole carboxamide ribonucleotide (AICAR) mimicked the effects of glucose starvation. Glucose deprivation increased the phosphorylation of IRS-1 on serine-789, but phosphomimetics revealed that this conferred negative regulation. Glucose deprivation enhanced tyrosine phosphorylation of IRS-1 and the insulin receptor, effects that were blocked by AMPK inhibition and mimicked by AICAR. In vitro kinase assays using purified proteins confirmed that the insulin receptor is a direct target of AMPK.
Conclusions/interpretation
AMPK phosphorylates and activates the insulin receptor, providing a direct link between AMPK and the insulin signalling pathway; this pathway promotes energy conservation and survival of muscle exposed to severe glucose deprivation. |
doi_str_mv | 10.1007/s00125-011-2407-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4648248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1008830041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-5e2df963d5c702988f06177310ebc10981ee8ea5d9f1b4f1b7bad60d06e1aa263</originalsourceid><addsrcrecordid>eNp1kstu1TAQhiMEoofCA7BBFhJSWQTGTuI4G6Sq4iaK6AIkdpbjTBKXxA52UpQ34jFxOIcWECx80cw3_4w9kyQPKTyjAOXzAEBZkQKlKcuhTNdbyY7mGUshZ-J2stvcKRX881FyL4RLAMiKnN9NjhhjUBbAdsn3i96FqXd-HdRsnCWuJXOPxNiwDMYSjxqn2XlSr-T0_UWq9Gyu1IwNmbybMRJfjFUByUn0vnu6WcdoD2QwnbJNamyDE8bNzuQQ-48swXRWDfHWkUnN_Te1ki23-xk2LkEPeD-506oh4IPDeZx8evXy49mb9PzD67dnp-epLjI6pwWypq141hS6BFYJ0QKnZZlRwFpTqARFFKiKpmppncdV1qrh0ABHqhTj2XHyYq87LfWIjY4VeDXIyZtR-VU6ZeSfHmt62bkrmfNcsFxEgZODgHdfFwyzHE3QOAzKoluCjJ0TIgPIaUQf_4VeusXHnwiyoqLkGeObHt1D2rsQPLbXtVDYxEq5HwMZx0BuYyDXGPPo90dcR_zqewSeHAAVtBpar6w24YYripLlRRU5tudCdNkO_U2F_8_-A4Vez2I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>918763268</pqid></control><display><type>article</type><title>Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Chopra, I. ; Li, H. F. ; Wang, H. ; Webster, K. A.</creator><creatorcontrib>Chopra, I. ; Li, H. F. ; Wang, H. ; Webster, K. A.</creatorcontrib><description>Aims/hypothesis
Muscle may experience hypoglycaemia during ischaemia or insulin infusion. During severe hypoglycaemia energy production is blocked, and an increase of AMP:ATP activates the energy sensor and putative insulin-sensitiser AMP-activated protein kinase (AMPK). AMPK promotes energy conservation and survival by shutting down anabolism and activating catabolic pathways. We investigated the molecular mechanism of a unique glucose stress defence pathway involving AMPK-dependent, insulin-independent activation of the insulin signalling pathway.
Methods
Cardiac or skeletal myocytes were subjected to glucose and insulin-free incubation for increasing intervals up to 20 h. AMPK, and components of the insulin signalling pathway and their targets were quantified by western blot using phosphor-specific antibodies. Phosphomimetics were used to determine the function of IRS-1 Ser789 phosphorylation and in vitro [
32
P]ATP kinase assays were used to measure the phosphorylation of the purified insulin receptor by AMPK.
Results
Glucose deprivation increased Akt-Thr308 and Akt-Ser473 phosphorylation by almost tenfold. Phosphorylation of glycogen synthase kinase 3 beta increased in parallel, but phosphorylation of ribosomal 70S subunit-S6 protein kinase and mammalian target of rapamycin decreased. AMPK inhibitors blocked and aminoimidazole carboxamide ribonucleotide (AICAR) mimicked the effects of glucose starvation. Glucose deprivation increased the phosphorylation of IRS-1 on serine-789, but phosphomimetics revealed that this conferred negative regulation. Glucose deprivation enhanced tyrosine phosphorylation of IRS-1 and the insulin receptor, effects that were blocked by AMPK inhibition and mimicked by AICAR. In vitro kinase assays using purified proteins confirmed that the insulin receptor is a direct target of AMPK.
Conclusions/interpretation
AMPK phosphorylates and activates the insulin receptor, providing a direct link between AMPK and the insulin signalling pathway; this pathway promotes energy conservation and survival of muscle exposed to severe glucose deprivation.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-011-2407-y</identifier><identifier>PMID: 22207502</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>AMP-Activated Protein Kinases - antagonists & inhibitors ; AMP-Activated Protein Kinases - metabolism ; Animals ; Animals, Newborn ; Biological and medical sciences ; Cell growth ; Cells, Cultured ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Energy conservation ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Fatty acids ; Glucose ; Hep G2 Cells ; Human Physiology ; Humans ; Hypoglycemia ; Hypoglycemia - metabolism ; Hypoglycemic Agents - pharmacology ; insulin ; Insulin Receptor Substrate Proteins - genetics ; Insulin Receptor Substrate Proteins - metabolism ; Insulin resistance ; Internal Medicine ; Kinases ; Ligands ; Lymphoma ; Medical sciences ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Metabolism ; Muscle, Skeletal - cytology ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - metabolism ; Muscles ; Mutant Proteins - metabolism ; Myocytes, Cardiac - cytology ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Phosphorylation ; Phosphorylation - drug effects ; Protein Kinase Inhibitors - pharmacology ; Protein Processing, Post-Translational - drug effects ; Proteins ; Rats ; Receptor, Insulin - isolation & purification ; Receptor, Insulin - metabolism ; Recombinant Proteins - metabolism ; rodents ; Sensors ; Signal transduction ; Signal Transduction - drug effects ; Stress ; survival</subject><ispartof>Diabetologia, 2012-03, Vol.55 (3), p.783-794</ispartof><rights>Springer-Verlag 2011</rights><rights>2015 INIST-CNRS</rights><rights>Springer-Verlag 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-5e2df963d5c702988f06177310ebc10981ee8ea5d9f1b4f1b7bad60d06e1aa263</citedby><cites>FETCH-LOGICAL-c531t-5e2df963d5c702988f06177310ebc10981ee8ea5d9f1b4f1b7bad60d06e1aa263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00125-011-2407-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00125-011-2407-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25572459$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22207502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chopra, I.</creatorcontrib><creatorcontrib>Li, H. F.</creatorcontrib><creatorcontrib>Wang, H.</creatorcontrib><creatorcontrib>Webster, K. A.</creatorcontrib><title>Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Aims/hypothesis
Muscle may experience hypoglycaemia during ischaemia or insulin infusion. During severe hypoglycaemia energy production is blocked, and an increase of AMP:ATP activates the energy sensor and putative insulin-sensitiser AMP-activated protein kinase (AMPK). AMPK promotes energy conservation and survival by shutting down anabolism and activating catabolic pathways. We investigated the molecular mechanism of a unique glucose stress defence pathway involving AMPK-dependent, insulin-independent activation of the insulin signalling pathway.
Methods
Cardiac or skeletal myocytes were subjected to glucose and insulin-free incubation for increasing intervals up to 20 h. AMPK, and components of the insulin signalling pathway and their targets were quantified by western blot using phosphor-specific antibodies. Phosphomimetics were used to determine the function of IRS-1 Ser789 phosphorylation and in vitro [
32
P]ATP kinase assays were used to measure the phosphorylation of the purified insulin receptor by AMPK.
Results
Glucose deprivation increased Akt-Thr308 and Akt-Ser473 phosphorylation by almost tenfold. Phosphorylation of glycogen synthase kinase 3 beta increased in parallel, but phosphorylation of ribosomal 70S subunit-S6 protein kinase and mammalian target of rapamycin decreased. AMPK inhibitors blocked and aminoimidazole carboxamide ribonucleotide (AICAR) mimicked the effects of glucose starvation. Glucose deprivation increased the phosphorylation of IRS-1 on serine-789, but phosphomimetics revealed that this conferred negative regulation. Glucose deprivation enhanced tyrosine phosphorylation of IRS-1 and the insulin receptor, effects that were blocked by AMPK inhibition and mimicked by AICAR. In vitro kinase assays using purified proteins confirmed that the insulin receptor is a direct target of AMPK.
Conclusions/interpretation
AMPK phosphorylates and activates the insulin receptor, providing a direct link between AMPK and the insulin signalling pathway; this pathway promotes energy conservation and survival of muscle exposed to severe glucose deprivation.</description><subject>AMP-Activated Protein Kinases - antagonists & inhibitors</subject><subject>AMP-Activated Protein Kinases - metabolism</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Biological and medical sciences</subject><subject>Cell growth</subject><subject>Cells, Cultured</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Energy conservation</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Fatty acids</subject><subject>Glucose</subject><subject>Hep G2 Cells</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Hypoglycemia - metabolism</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>insulin</subject><subject>Insulin Receptor Substrate Proteins - genetics</subject><subject>Insulin Receptor Substrate Proteins - metabolism</subject><subject>Insulin resistance</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Ligands</subject><subject>Lymphoma</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases</subject><subject>Metabolism</subject><subject>Muscle, Skeletal - cytology</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Muscles</subject><subject>Mutant Proteins - metabolism</subject><subject>Myocytes, Cardiac - cytology</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Phosphorylation</subject><subject>Phosphorylation - drug effects</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Protein Processing, Post-Translational - drug effects</subject><subject>Proteins</subject><subject>Rats</subject><subject>Receptor, Insulin - isolation & purification</subject><subject>Receptor, Insulin - metabolism</subject><subject>Recombinant Proteins - metabolism</subject><subject>rodents</subject><subject>Sensors</subject><subject>Signal transduction</subject><subject>Signal Transduction - drug effects</subject><subject>Stress</subject><subject>survival</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kstu1TAQhiMEoofCA7BBFhJSWQTGTuI4G6Sq4iaK6AIkdpbjTBKXxA52UpQ34jFxOIcWECx80cw3_4w9kyQPKTyjAOXzAEBZkQKlKcuhTNdbyY7mGUshZ-J2stvcKRX881FyL4RLAMiKnN9NjhhjUBbAdsn3i96FqXd-HdRsnCWuJXOPxNiwDMYSjxqn2XlSr-T0_UWq9Gyu1IwNmbybMRJfjFUByUn0vnu6WcdoD2QwnbJNamyDE8bNzuQQ-48swXRWDfHWkUnN_Te1ki23-xk2LkEPeD-506oh4IPDeZx8evXy49mb9PzD67dnp-epLjI6pwWypq141hS6BFYJ0QKnZZlRwFpTqARFFKiKpmppncdV1qrh0ABHqhTj2XHyYq87LfWIjY4VeDXIyZtR-VU6ZeSfHmt62bkrmfNcsFxEgZODgHdfFwyzHE3QOAzKoluCjJ0TIgPIaUQf_4VeusXHnwiyoqLkGeObHt1D2rsQPLbXtVDYxEq5HwMZx0BuYyDXGPPo90dcR_zqewSeHAAVtBpar6w24YYripLlRRU5tudCdNkO_U2F_8_-A4Vez2I</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Chopra, I.</creator><creator>Li, H. F.</creator><creator>Wang, H.</creator><creator>Webster, K. A.</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7ST</scope><scope>7U6</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20120301</creationdate><title>Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle</title><author>Chopra, I. ; Li, H. F. ; Wang, H. ; Webster, K. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-5e2df963d5c702988f06177310ebc10981ee8ea5d9f1b4f1b7bad60d06e1aa263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>AMP-Activated Protein Kinases - antagonists & inhibitors</topic><topic>AMP-Activated Protein Kinases - metabolism</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Biological and medical sciences</topic><topic>Cell growth</topic><topic>Cells, Cultured</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Energy conservation</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Fatty acids</topic><topic>Glucose</topic><topic>Hep G2 Cells</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Hypoglycemia - metabolism</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>insulin</topic><topic>Insulin Receptor Substrate Proteins - genetics</topic><topic>Insulin Receptor Substrate Proteins - metabolism</topic><topic>Insulin resistance</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Ligands</topic><topic>Lymphoma</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases</topic><topic>Metabolism</topic><topic>Muscle, Skeletal - cytology</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Muscles</topic><topic>Mutant Proteins - metabolism</topic><topic>Myocytes, Cardiac - cytology</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Phosphorylation</topic><topic>Phosphorylation - drug effects</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Protein Processing, Post-Translational - drug effects</topic><topic>Proteins</topic><topic>Rats</topic><topic>Receptor, Insulin - isolation & purification</topic><topic>Receptor, Insulin - metabolism</topic><topic>Recombinant Proteins - metabolism</topic><topic>rodents</topic><topic>Sensors</topic><topic>Signal transduction</topic><topic>Signal Transduction - drug effects</topic><topic>Stress</topic><topic>survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chopra, I.</creatorcontrib><creatorcontrib>Li, H. F.</creatorcontrib><creatorcontrib>Wang, H.</creatorcontrib><creatorcontrib>Webster, K. A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environment Abstracts</collection><collection>Sustainability Science Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chopra, I.</au><au>Li, H. F.</au><au>Wang, H.</au><au>Webster, K. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>55</volume><issue>3</issue><spage>783</spage><epage>794</epage><pages>783-794</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>Aims/hypothesis
Muscle may experience hypoglycaemia during ischaemia or insulin infusion. During severe hypoglycaemia energy production is blocked, and an increase of AMP:ATP activates the energy sensor and putative insulin-sensitiser AMP-activated protein kinase (AMPK). AMPK promotes energy conservation and survival by shutting down anabolism and activating catabolic pathways. We investigated the molecular mechanism of a unique glucose stress defence pathway involving AMPK-dependent, insulin-independent activation of the insulin signalling pathway.
Methods
Cardiac or skeletal myocytes were subjected to glucose and insulin-free incubation for increasing intervals up to 20 h. AMPK, and components of the insulin signalling pathway and their targets were quantified by western blot using phosphor-specific antibodies. Phosphomimetics were used to determine the function of IRS-1 Ser789 phosphorylation and in vitro [
32
P]ATP kinase assays were used to measure the phosphorylation of the purified insulin receptor by AMPK.
Results
Glucose deprivation increased Akt-Thr308 and Akt-Ser473 phosphorylation by almost tenfold. Phosphorylation of glycogen synthase kinase 3 beta increased in parallel, but phosphorylation of ribosomal 70S subunit-S6 protein kinase and mammalian target of rapamycin decreased. AMPK inhibitors blocked and aminoimidazole carboxamide ribonucleotide (AICAR) mimicked the effects of glucose starvation. Glucose deprivation increased the phosphorylation of IRS-1 on serine-789, but phosphomimetics revealed that this conferred negative regulation. Glucose deprivation enhanced tyrosine phosphorylation of IRS-1 and the insulin receptor, effects that were blocked by AMPK inhibition and mimicked by AICAR. In vitro kinase assays using purified proteins confirmed that the insulin receptor is a direct target of AMPK.
Conclusions/interpretation
AMPK phosphorylates and activates the insulin receptor, providing a direct link between AMPK and the insulin signalling pathway; this pathway promotes energy conservation and survival of muscle exposed to severe glucose deprivation.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>22207502</pmid><doi>10.1007/s00125-011-2407-y</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-186X |
ispartof | Diabetologia, 2012-03, Vol.55 (3), p.783-794 |
issn | 0012-186X 1432-0428 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4648248 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | AMP-Activated Protein Kinases - antagonists & inhibitors AMP-Activated Protein Kinases - metabolism Animals Animals, Newborn Biological and medical sciences Cell growth Cells, Cultured Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Energy conservation Etiopathogenesis. Screening. Investigations. Target tissue resistance Fatty acids Glucose Hep G2 Cells Human Physiology Humans Hypoglycemia Hypoglycemia - metabolism Hypoglycemic Agents - pharmacology insulin Insulin Receptor Substrate Proteins - genetics Insulin Receptor Substrate Proteins - metabolism Insulin resistance Internal Medicine Kinases Ligands Lymphoma Medical sciences Medicine Medicine & Public Health Metabolic Diseases Metabolism Muscle, Skeletal - cytology Muscle, Skeletal - drug effects Muscle, Skeletal - metabolism Muscles Mutant Proteins - metabolism Myocytes, Cardiac - cytology Myocytes, Cardiac - drug effects Myocytes, Cardiac - metabolism Phosphorylation Phosphorylation - drug effects Protein Kinase Inhibitors - pharmacology Protein Processing, Post-Translational - drug effects Proteins Rats Receptor, Insulin - isolation & purification Receptor, Insulin - metabolism Recombinant Proteins - metabolism rodents Sensors Signal transduction Signal Transduction - drug effects Stress survival |
title | Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T19%3A46%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phosphorylation%20of%20the%20insulin%20receptor%20by%20AMP-activated%20protein%20kinase%20(AMPK)%20promotes%20ligand-independent%20activation%20of%20the%20insulin%20signalling%20pathway%20in%20rodent%20muscle&rft.jtitle=Diabetologia&rft.au=Chopra,%20I.&rft.date=2012-03-01&rft.volume=55&rft.issue=3&rft.spage=783&rft.epage=794&rft.pages=783-794&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-011-2407-y&rft_dat=%3Cproquest_pubme%3E1008830041%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=918763268&rft_id=info:pmid/22207502&rfr_iscdi=true |